SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 95 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $302,960,000 | +70.6% | 27,050 | +67.6% | 0.00% | 0.0% |
| Q2 2017 | $177,540,000 | +72.8% | 16,140 | +54.0% | 0.00% | – |
| Q1 2017 | $102,724,000 | +3.8% | 10,482 | +14.4% | 0.00% | – |
| Q4 2016 | $98,950,000 | +37.6% | 9,162 | +30.6% | 0.00% | – |
| Q3 2016 | $71,935,000 | -64.7% | 7,018 | -55.0% | 0.00% | -100.0% |
| Q2 2016 | $203,540,000 | +136.9% | 15,585 | +66.9% | 0.00% | – |
| Q4 2015 | $85,928,000 | +18.6% | 9,340 | -10.6% | 0.00% | – |
| Q3 2015 | $72,481,000 | +78.9% | 10,444 | +153.1% | 0.00% | – |
| Q2 2015 | $40,517,000 | +272.4% | 4,126 | +236.0% | 0.00% | – |
| Q1 2015 | $10,880,000 | -45.4% | 1,228 | -57.6% | 0.00% | – |
| Q3 2014 | $19,933,000 | +4524.8% | 2,893 | +3428.0% | 0.00% | – |
| Q2 2014 | $431,000 | -78.9% | 82 | -80.8% | 0.00% | – |
| Q1 2014 | $2,041,000 | -61.0% | 427 | -58.9% | 0.00% | – |
| Q4 2013 | $5,237,000 | -93.1% | 1,039 | -93.1% | 0.00% | – |
| Q3 2013 | $76,446,000 | -13.9% | 15,078 | -15.7% | 0.00% | – |
| Q2 2013 | $88,754,000 | – | 17,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |